SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 46.50 |
| Enterprise Value ($M) | 7.10 |
| Book Value ($M) | 125.93 |
| Book Value / Share | 3.01 |
| Price / Book | 0.37 |
| NCAV ($M) | 111.59 |
| NCAV / Share | 2.66 |
| Price / NCAV | 0.42 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.37 |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | -0.32 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 11.80 |
| Current Ratio | 11.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 127.17 |
| Assets | 141.51 |
| Liabilities | 15.58 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -54.55 |
| Net Income | -49.23 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -46.00 |
| Cash from Investing | -34.90 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BML Investment Partners, L.P. | 7.60 | ||
| 13G | Deep Track Capital, LP | 5.21 | ||
| 13G/A | Biotechnology Value Fund L P | 8.30 | -15.99 | |
| 13G/A | Gilead Sciences Inc | 3.60 | -48.10 | |
| 13G | Blue Owl Capital Holdings LP | 8.48 | ||
| 13G/A | Bristol Myers Squibb Co | 4.40 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 21,207 | 138,073 | 15.36 | |
| 14,756 | 50,595 | 29.16 | |
| 1,565 | 31,903 | 4.91 | |
| 3,432 | 40,653 | 8.44 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GHRS – GH Research PLC | HRMY – Harmony Biosciences Holdings, Inc. |
| HROW – Harrow, Inc. | IMRX – Immuneering Corporation |
| IOVA – Iovance Biotherapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io